TeraWulf
WULF
Bitdeer Technologies
BTDR
Riot Platforms
RIOT
Bitfarms
BITF
CleanSpark
CLSK
US Stock MarketDetailed Quotes
IONS Ionis Pharmaceuticals
- 33.190
- +1.840+5.87%
Close Feb 28 16:00 ET
- 33.190
- 0.0000.00%
Post 20:01 ET
5.28BMarket Cap-10.92P/E (TTM)
33.300High31.120Low2.01MVolume31.310Open31.350Pre Close65.63MTurnover1.28%Turnover RatioLossP/E (Static)158.96MShares52.34052wk High8.97P/B5.23BFloat Cap30.23052wk Low--Dividend TTM157.59MShs Float86.582Historical High--Div YieldTTM6.95%Amplitude2.500Historical Low32.669Avg Price1Lot Size
Ionis Pharmaceuticals News
Stifel Maintains Ionis Pharmaceuticals(IONS.US) With Hold Rating, Maintains Target Price $38
Stifel Nicolaus Remains a Hold on Ionis Pharmaceuticals (IONS)
Bernstein Maintains Ionis Pharmaceuticals(IONS.US) With Hold Rating, Cuts Target Price to $43
Ionis Pharmaceuticals Is Maintained at Market Perform by BMO Capital
BMO Capital Maintains Ionis Pharmaceuticals(IONS.US) With Hold Rating, Cuts Target Price to $45
RBC Capital Maintains Ionis Pharmaceuticals(IONS.US) With Buy Rating, Maintains Target Price $70
Citi Maintains Ionis Pharmaceuticals(IONS.US) With Buy Rating, Cuts Target Price to $64
A Quick Look at Today's Ratings for Ionis Pharmaceuticals(IONS.US), With a Forecast Between $38 to $70
Ionis Pharmaceuticals: Balancing Strong R&D Revenues With Market Challenges – Hold Rating Justified
Ionis Pharmaceuticals Analyst Ratings
Barclays Remains a Hold on Ionis Pharmaceuticals (IONS)
Analysts' Opinions Are Mixed on These Healthcare Stocks: Ionis Pharmaceuticals (IONS), Stryker (SYK) and Bausch + Lomb Corporation (BLCO)
Ionis Pharmaceuticals: Strong Revenue Performance and Promising Catalysts Drive Buy Rating
Wells Fargo Maintains Ionis Pharmaceuticals(IONS.US) With Buy Rating, Maintains Target Price $77
Bernstein Maintains Ionis Pharmaceuticals(IONS.US) With Hold Rating, Maintains Target Price $51
Ionis Pharmaceuticals (IONS) Gets a Hold From Bernstein
Ionis Pharmaceuticals Analyst Ratings
RBC Capital Maintains Ionis Pharmaceuticals(IONS.US) With Buy Rating, Maintains Target Price $70
RBC Capital Sticks to Its Buy Rating for Ionis Pharmaceuticals (IONS)
Citi Maintains Ionis Pharmaceuticals(IONS.US) With Buy Rating, Maintains Target Price $67
Trending Stocks
U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks
Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.